Huang Su

A randomized noninferiority trial comparing tegoprazan triple therapy and bismuth quadruple therapy for Helicobacter pylori eradication

Abstract Rising antibiotic resistance has compromised the efficacy of standard Helicobacter pylori ( H. pylori ) eradication regimens. This multicenter trial aimed to evaluate whether a simplified tegoprazan-based triple therapy (TAD) is non-inferior to tegoprazan-based bismuth q...